Yaohua Yang, PhD, of UVA’s Department of Genome Sciences has been awarded a five-year, $3.5 million NCI R37 MERIT grant to study RNA modifications called m6A marks and their role in lung cancer risk.
UVA researchers discovered how an unhealthy gut may help breast cancer spread – and how an existing drug could potentially stop it.
New research from the UVA Department of Surgery’s Tsung Research Group, published in JAMA Network Open and selected as an Editor’s Pick, provides a national evaluation of real-world use of histotripsy for liver tumors.
UVA Health researchers have found that gliomas, the most common primary brain tumors in adults, may be more receptive to focused ultrasound drug delivery than normal brain tissue.
UVA’s Center for Systems Analysis of Stress-adapted Cancer Organelles (SASCO) recently held its annual symposium, hosting a pair of leading figures in breast cancer research and sharing findings including identification […]
UVA scientists have developed a promising new approach to targeting glioblastoma, the most common and deadliest brain cancer, that could overcome limitations of existing drugs.
GET THE STORIES BEHIND THE RESEARCH
Receive updates about the discoveries, researchers, and ideas shaping our world — straight from UVA.
New research from UVA’s Melanie Rutkowski, PhD, and colleagues helps explain how the gut microbiome – the collection of microorganisms that live in and on our intestines – plays a role in the spread of hormone receptor-positive (HR+) breast cancer.
A University of Virginia School of Engineering and Applied Science faculty researcher earned a major new federal grant to develop emerging tools to work with some of the rarest circulating cells in the human body, a step toward better treatments for diseases such as cancer and infection.
Mark Conaway, PhD, professor of in the Department of Public Health Sciences, and UVA Researchers have been awarded a four-year, $1.95 million NIH R01 grant to investigate two significant clinical questions: 1) how should ELISpot assay data be used in early phase clinical trials to identify potentially effective therapies and 2) can ELISpot assay data predict longer term clinical benefit.
Strange “chimeric” RNA once thought to be the product of cancer is actually an important controller of women’s health, including influencing their susceptibility to infectious disease and autoimmune disorders, new University of Virginia School of Medicine research suggests.
University of Virginia researchers are piloting weSIPsmarter, a digital program aimed at reducing sugary drink consumption among rural families in Appalachia and the South. Funded by a $669,251 National Cancer Institute grant, the initiative targets Head Start families across five states, focusing on parents and children ages 2–5, who face elevated health risks including cancer, heart disease, and diabetes linked to high sugary drink intake.
Noelle D. Dwyer and team have revealed how mistakes in the final step of cell division can have dire consequences for developing brain cells.